Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 237 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2778 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-17 | 122468 |
APO-QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-31 | 122495 |
APO-QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-19 | 2020-09-04 | 122497 |
APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2020-10-07 | 2020-12-07 | 125800 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-10 | 131142 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-03-05 | 2021-03-15 | 135156 |
APO-QUETIAPINE | 200MG | TABLET | Actual shortage | 2021-06-11 | 2021-08-27 | 140788 |
APO-QUETIAPINE | 200MG | TABLET | Resolved | 2021-06-25 | 2021-08-25 | 141543 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-08-03 | 2021-09-27 | 143397 |
APO-IBUPROFEN | 200MG | TABLET | Resolved | 2022-02-11 | 2022-05-14 | 154762 |
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2022-04-08 | 2022-04-13 | 158339 |
APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2022-06-17 | 2022-09-23 | 162899 |
APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174636 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2022-12-02 | 2023-01-26 | 176942 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2022-12-09 | 2023-01-26 | 177615 |
APO-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-09 | 2022-12-16 | 177672 |
APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2023-02-16 | 2023-05-26 | 185028 |
APO-ACEBUTOLOL | 200MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185448 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2023-02-23 | 2023-03-02 | 185471 |
APO-LABETALOL | 200MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185489 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |